These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28182613)

  • 1. News on Viral Hepatitis in HIV: Update from the 2016 GEHEP Conference.
    Poveda E; Puoti M; García-Deltoro M; Pineda JA; Téllez F; Granados R; Morano L; García F
    AIDS Rev; 2017; 19(1):47-53. PubMed ID: 28182613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. News on HIV-HCV Coinfection: Update From the 2015 GEHEP Conference.
    Poveda E; Wyles D; Morano L; Pineda JA; García F;
    AIDS Rev; 2015; 17(4):231-7. PubMed ID: 26616846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report from the International Conference on Viral Hepatitis (ICVH), San Francisco, March 2016.
    Soriano V; Young B; Terrault N
    AIDS Rev; 2016; 18(2):81-8. PubMed ID: 27196355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report from the International Conference on Viral Hepatitis - 2017.
    Soriano V; Young B; Reau N
    AIDS Rev; 2018; 20(1):58-70. PubMed ID: 29369303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatitis C in HIV-coinfected patients.
    Hughes CA; Shafran SD
    Ann Pharmacother; 2006 Mar; 40(3):479-89; quiz 582-3. PubMed ID: 16507622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of human immunodeficiency virus on viral hepatitis.
    Mallet V; Vallet-Pichard A; Pol S
    Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C.
    Pineda JA; Núñez-Torres R; Téllez F; Mancebo M; García F; Merchante N; Pérez-Pérez M; Neukam K; Macías J; Real LM;
    J Infect; 2015 Nov; 71(5):571-7. PubMed ID: 26212868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
    Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
    AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HCV / HIV co-infection: a different perspective].
    Jmelnitzky AC
    Acta Gastroenterol Latinoam; 2002 May; 32(1):7-10. PubMed ID: 12136694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human immunodeficiency virus infection and viral hepatitis].
    Soriano V; Martin-Carbonero L; Vispo E; Labarga P; Barreiro P
    Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):691-701. PubMed ID: 21978797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral hepatitis and HIV coinfection.
    Sulkowski MS
    J Hepatol; 2008 Feb; 48(2):353-67. PubMed ID: 18155314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New pharmacotherapy for hepatitis C.
    Assis DN; Lim JK
    Clin Pharmacol Ther; 2012 Sep; 92(3):294-305. PubMed ID: 22850602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hepatitis C in HIV infected and other immunocompromised individuals.
    Seth AK
    Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.
    Walsh N; Maher L
    Curr Opin HIV AIDS; 2012 Jul; 7(4):339-44. PubMed ID: 22498482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does HIV Influence Hepatitis C Cure Rates Using Direct-Acting Antivirals?
    de Mendoza C
    AIDS Rev; 2016; 18(2):112-3. PubMed ID: 27232507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coinfection with hepatitis C virus and HIV].
    Ruys TA; Reesink HW; Lange JM
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2056-60. PubMed ID: 14606352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of end-stage liver disease in HIV/hepatitis C virus co-infection.
    Spengler U
    Curr Opin HIV AIDS; 2011 Nov; 6(6):527-33. PubMed ID: 21918437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.